Amicus Therapeutics (FOLD) –
-
Form ARS AMICUS THERAPEUTICS, For: Dec 31
-
Form DEF 14A AMICUS THERAPEUTICS, For: Jun 06
-
Form DEFA14A AMICUS THERAPEUTICS,
-
Form 4 AMICUS THERAPEUTICS, For: Apr 15 Filed by: Prout Samantha
-
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
-
Amicus Therapeutics (FOLD) PT Lowered to $14 at BofA Securities
-
Form 4 AMICUS THERAPEUTICS, For: Apr 01 Filed by: Campbell Bradley L
-
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
-
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
-
WuXi Biologics Reports Solid 2023 Annual Results
-
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
-
Form 4 AMICUS THERAPEUTICS, For: Mar 15 Filed by: Campbell Bradley L
-
Amicus Therapeutics (FOLD) PT Lowered to $19 at JPMorgan
-
Form 4/A AMICUS THERAPEUTICS, For: Jan 09 Filed by: Campbell Bradley L
-
Form 4/A AMICUS THERAPEUTICS, For: Jan 09 Filed by: Crowley John F
-
Form 4/A AMICUS THERAPEUTICS, For: Jan 09 Filed by: Clark David Michael
-
Form 4/A AMICUS THERAPEUTICS, For: Jan 09 Filed by: Castelli Jeff
-
Form 4/A AMICUS THERAPEUTICS, For: Jan 09 Filed by: Rosenberg Ellen
-
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
-
Form 4 AMICUS THERAPEUTICS, For: Mar 07 Filed by: SBLENDORIO GLENN
-
Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: RAAB MICHAEL
-
Form 4 AMICUS THERAPEUTICS, For: Mar 04 Filed by: MCGLYNN MARGARET G
-
Form 4 AMICUS THERAPEUTICS, For: Mar 01 Filed by: Crowley John F
-
Form 4 AMICUS THERAPEUTICS, For: Mar 01 Filed by: Campbell Bradley L
-
Form 144 AMICUS THERAPEUTICS, Filed by: MCGLYNN MARGARET G
-
Form 144 AMICUS THERAPEUTICS, Filed by: MCGLYNN MARGARET G
-
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
-
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
-
Form 10-K AMICUS THERAPEUTICS, For: Dec 31
-
Amicus Therapeutics (FOLD) Tops Q4 EPS by 7c, provides guidance
-
Form 8-K AMICUS THERAPEUTICS, For: Feb 28
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
-
Form 4 AMICUS THERAPEUTICS, For: Feb 15 Filed by: Crowley John F
-
Form 4 AMICUS THERAPEUTICS, For: Feb 15 Filed by: Campbell Bradley L
-
Form 4 AMICUS THERAPEUTICS, For: Feb 15 Filed by: Clark David Michael
-
Form 144 AMICUS THERAPEUTICS, Filed by: Crowley John F
-
Form 144 AMICUS THERAPEUTICS, Filed by: Campbell Bradley L
-
Form 144 AMICUS THERAPEUTICS, Filed by: Clark David Michael
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
-
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Redmile Group, LLC
-
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Avoro Capital Advisors LLC
-
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: VANGUARD GROUP INC
-
Form 4 AMICUS THERAPEUTICS, For: Feb 06 Filed by: Rosenberg Ellen
-
Form SC 13G AMICUS THERAPEUTICS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
-
Form 144 AMICUS THERAPEUTICS, Filed by: Rosenberg Ellen
-
Form 4 AMICUS THERAPEUTICS, For: Feb 01 Filed by: Campbell Bradley L
-
Form 4 AMICUS THERAPEUTICS, For: Feb 01 Filed by: Crowley John F
Back to FOLD Stock Lookup